The constitutional economics of the World Health Organization.


Journal

Health economics, policy, and law
ISSN: 1744-134X
Titre abrégé: Health Econ Policy Law
Pays: England
ID NLM: 101247224

Informations de publication

Date de publication:
07 2021
Historique:
pubmed: 4 8 2020
medline: 25 6 2021
entrez: 4 8 2020
Statut: ppublish

Résumé

This paper brings a constitutional economics perspective to bear on the World Health Organization (WHO), the flagship United Nations intergovernmental health organisation, which is obligated by its Constitution to achieve 'the highest possible level of health' for the world's peoples. The WHO has in the seven decades of its existence used its formidable legislative powers only sparingly. It has been widely chided for being weak in regional coordination and unresponsive to transnational emergencies like the West African Ebola outbreak of 2014-2016. In 2020, it found itself at the centre of the COVID-19 pandemic and in the middle of the Sino-American geopolitical tug-of-war. This paper traces the discordance between the Constitution's stated purposes and the actual track record of the WHO not back to its organisational culture nor to weak leadership but to the design of the Constitution itself. It analytically distinguishes the Constitution's expressive from its instrumental halves, and shows that, whilst the former embodies a 'constitutional moment' of international health solidarity right after the Second World War, the latter embodies a reserved and limited delegation from member-states that are jealous of their sovereignty.

Identifiants

pubmed: 32744214
doi: 10.1017/S1744133120000249
pii: S1744133120000249
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

325-339

Auteurs

Eric C Ip (EC)

Centre for Medical Ethics and Law, The University of Hong Kong, Hong Kong SAR, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH